TMFUltraLong

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and investment planning. You'll often find him writing about Obamacare, marijuana, drug and device development, Social Security, taxes, retirement issues and general macroeconomic topics of interest.

TMFUltraLong’s Activity

Thu Jan 12

NL

Article

TMFUltraLong published an article 12:00 AM

Will This Be a Genius or Foolish Move for Johnson & Johnson?

Disclosing its 2016 prescription drug price increases is a double-edged sword.

Wed Jan 11

NL

Article

TMFUltraLong published an article 12:00 AM

7 Shocking Ways You Could Be Hurting Your Credit Score Without Realizing It

Ignorance isn't bliss in when it comes to your credit.

NL

Article

TMFUltraLong published an article 12:00 AM

Donald Trump Just Leveled Drug Companies With These 4 Words

Pharma and biotech companies have been put on notice, but so has Donald Trump.

NL

Article

TMFUltraLong published an article 12:00 AM

The 3 Biggest Surprises From Silver Stocks in 2016

Silver stocks had a great year, but that doesn't mean things went as planned.

Tue Jan 10

NL

Article

TMFUltraLong published an article 12:00 AM

The Reason Behind Brookdale Senior Living, Inc.'s 21% Spike Higher

Could Brookdale be on the auction block?

NL

Article

TMFUltraLong published an article 12:00 AM

This Is the Smartest Move Valeant Pharmaceuticals Has Made in a Really Long Time

But you still shouldn't buy Valeant's stock.

Mon Jan 9

NL

Article

TMFUltraLong published an article 12:00 AM

The 3 Most Likely Scenarios for Marijuana With Jeff Sessions as Attorney General

Should the pot industry fear Senator Jeff Sessions?

NL

Article

TMFUltraLong published an article 12:00 AM

1 Chart That Shows Why Americans Are Failing at Retirement

If you're struggling to save money for retirement, you're not alone.

NL

Article

TMFUltraLong published an article 12:00 AM

3 Tempting Stocks We're Avoiding

These tantalizing stocks could be nothing more than fool's gold.

Thu Jan 5

NL

Article

TMFUltraLong published an article 12:00 AM

2 Social Security Misconceptions That Are Wrecking Your Retirement

Not knowing this could cost you dearly.

NL

Article

TMFUltraLong published an article 12:00 AM

Gold and Silver Stocks Regain Their Luster, but Will It Last?

Improving fundamentals in some mining companies suggest there could be more upside to come.

Wed Jan 4

NL

Article

TMFUltraLong published an article 12:00 AM

Trump's Individual Income Tax Reforms Could Fail Most Americans

These big-league tax cuts come with big-league problems for lower- and middle-class Americans.

NL

Article

TMFUltraLong published an article 12:00 AM

Put Me on Record: Gold Will See $2,000 Before $1,000

Despite being just $170 away from $1,000 per ounce, these seven factors are likely to push gold to $2,000.

NL

Article

TMFUltraLong published an article 12:00 AM

2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016

A rival's pain was this drugmaker's big gain in 2016.

NL

Article

TMFUltraLong published an article 12:00 AM

Organovo Holdings Inc.'s 36% Ascent in 2016 Can Be Attributed to These 3 Factors

Things have finally begun to gel for Organovo, but investors shouldn't get too excited just yet.

NL

Article

TMFUltraLong published an article 12:00 AM

The Laundry List of Reasons Why Valeant Pharmaceuticals Intl. Inc. Plummeted 86% in 2016

If it could go wrong, it did for Valeant in 2016.

NL

Article

TMFUltraLong published an article 12:00 AM

It Was CheckMate for Bristol-Myers Squibb Company in 2016

Bristol-Myers' source of gains in previous years wound up being its primary source of frustration in 2016.

NL

Article

TMFUltraLong published an article 12:00 AM

The 2 Critical Cogs That Pushed Johnson & Johnson 12% Higher in 2016

Hint: It's all about the pharmaceutical segment!

Tue Jan 3

NL

Article

TMFUltraLong published an article 12:00 AM

3 Reasons Geron Corporation Plunged 57% in 2016

Here's a hint: imetelstat, imetelstat, imetelstat.

NL

Article

TMFUltraLong published an article 12:00 AM

The 4 Building Blocks That Pushed Exelixis, Inc. Higher by 164% in 2016

The biotech's run may not be done, with profitability right around the corner.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.82
Player Rank 132 out of 74695
Score 8501.46
Score Change Today +16.86
Accuracy 88.53%
Active Picks 97
Total Picks 506
Best Pick FAZ (+338.56)
Worst Pick PCYC.DL (-8878.78)
Average Score per Pick 16.94
Charms Earned 16
Highest Rated Favorite TMFBabo
Go to TMFUltraLong’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 3
Recs Received 11
People who have rec'd these posts 11
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board CAPS Feedback
Very First Post Tickering....Just a heads up... (10/14/2010)
Percentage of Posts Rec'd 100.00 %
Show TMFUltraLong’s 10 Latest Posts